---
title: Complications-treatment-chronic kidney disease  CKD 
---
# Complications-treatment-chronic kidney disease (CKD)

(JAMA 2019;322:1294; KI 2021;99:S1)

* General: renal referral when GFR <30 or proteinuria, access planning (avoid subclavian lines, preserve an arm by avoiding phlebotomy, BP measurements, IVs)
* CV risk reduction: consider usual preventive Rx including statin, βB, etc.
* Dietary restrictions: Na (if HTN), K (if oliguric or hyperkalemic), PO4, mod protein.
* Diabetes: strict glc control; ACEI/ARB, SGLT2i and MRA (NEJM 2020;383:2219) slow CKD progression (↓ glomerular pressure)

* [[SGLT2i in chronic kidney disease]]
* [[BP control in chronic kidney disease]]
* Metabolic acidosis: sodium bicarbonate or sodium citrate if low HCO3 (JASN 2015;26:515)
* Hyperkalemia: 2-g K diet, see “Potassium Homeostasis”
* [[Anemia in chronic kidney disease]]
* Uremic bleeding: desmopressin (dDAVP) 0.3 μg/kg IV or 3 μg/kg intranasally
* [[Secondary hyperPTH]]
* [[Calciphylaxis]]
* [[Anticoagulant in chronic kidney disease]]
* Transplant evaluation
